Pacjent z OSA - O czym warto pamiȩtać?

Kardiologia Polska

Volumn 70, Issue 1, 2012, Pages 30-

  Szymański, Filip M ^a  

^a WARSZAWSKI UNIWERSYTET MEDYCZNY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856237291     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (6)

1. Somers VK, White DP, Amin R et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol, 2008; 52: 686-717.
2. Wolk R, Kara T, Somers VK. Sleep-disordered breathing and cardiovascular disease. Circulation, 2003; 108: 9-12. (Pubitemid 36859012)
3. Hrynkiewicz-Szymanska A, Szymanski FM, Filipiak KJ et al. Can obstructive sleep apnea be a cause of in-stent thrombosis? Sleep Breath, 2011; 15: 607-609.
4. Narkiewicz K, van de Borne PJ, Cooley RL et al. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation, 1998; 98: 772-776. (Pubitemid 28391842)
5. Hernandez C, Abreu J, Abreu P et al. Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP. Eur Respir J, 2007; 30: 496-500. (Pubitemid 351182073)
6. Rechciński T, Uznańska-Loch B, Trzos E et al. Melatonin - a somniferous option which does not aggravate sleep-disordered breathing in cardiac risk patients: a Holter ECG based study. Kardiol Pol, 2012; 70: 24-29.